MetLife Inc
0K0X.L
$78.34 0.35%
Exchange: LSE | Sector: Financial Services | Industry: Insurance Diversified
Q2 2025
Published: Aug 7, 2025

Earnings Highlights

  • Revenue of $17.18B down 1.8% year-over-year
  • EPS of $1.03 decreased by 18.8% from previous year
  • Gross margin of 26.4%
  • Net income of 729.00M
  • "No transcript quotes are available in the provided data." -
0K0X.L
Company 0K0X.L

Executive Summary

MetLife reported Q2 2025 revenue of $17.18 billion, marking a YoY decline of 1.8% and a QoQ decrease of 5.95%. Despite the revenue headwinds, the company delivered a solid gross margin of 26.4% and an operating margin of 5.71%, with operating income of $0.98 billion and net income of $0.729 billion (EPS of $1.04). Profitability trends reflect a compression in operating efficiency versus prior periods, evidenced by a 18.5% YoY drop in operating income and a 22.9% decline in net income. The company also posted a diluted EPS of $1.03. On the balance sheet, MetLife exhibits substantial liquidity with cash and cash equivalents of $22.18 billion and a large asset base, supporting a net cash position (net debt) of approximately -$2.27 billion. Free cash flow for the quarter was robust at $2.19 billion, underscoring a strong cash-generating capability that funds dividends and buybacks while maintaining a conservative leverage profile. The LTM revenue stands near $72.18 billion with an estimated LTM diluted EPS around $1.48, consistent with a resilient but mature insurance franchise.

Key Performance Indicators

Revenue
Decreasing
17.18B
QoQ: -5.95% | YoY: -1.80%
Gross Profit
Increasing
4.54B
26.43% margin
QoQ: -3.83% | YoY: 3.46%
Operating Income
Decreasing
980.00M
QoQ: -27.62% | YoY: -18.47%
Net Income
Decreasing
729.00M
QoQ: -22.86% | YoY: -22.94%
EPS
Decreasing
1.04
QoQ: -19.38% | YoY: -18.75%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 17,361.00 1.22 -5.1% View
Q2 2025 17,176.00 1.03 -1.8% View
Q1 2025 18,263.00 1.28 +14.9% View
Q4 2024 18,440.00 1.78 -3.1% View
Q3 2024 18,298.00 1.81 +15.3% View